← Russell 3000 cross-section

BFLY Butterfly Network, Inc.

Trailing twelve months to 2026-06-30 · as filed 2026-07-30, not restated
Healthcare

Scale

Market cap
$2.4bn
Revenue TTM
$112m
Net income TTM
$-75m
Free cash flow
$-28m
Composite score
43.5
Sector rank
#1532

Valuation

P / E
EV / EBITDA
EV / sales
20.4
FCF yield
-1.16%
Earnings yield vs 10-yr
-7.84pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-66.7%
EBITDA margin
ROE
-39.5%
ROIC
-122.6%
Revenue growth
28.1%

Insider activity, last 90 days

Net open-market
$-95.95m
Buyers
1
Sellers
8

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

The increase was largely driven by higher probe sales volume in the U.S. through direct sales to health systems and medical schools as well as our eCommerce sales channel. Over time, as adoption of our devices increases through further market penetration, as practitioners in the Butterfly network continue to use our devices, and as our Embedded collaborations continue to grow and develop, we expect our annual revenue mix to shift more toward software and other services. As we expand our healthcare system software offerings and develop relationships with larger healthcare systems, we continue to expect a higher proportion of our sales in healthcare systems compared to eCommerce. …Butterfly Network, Inc., 10-Q, period ended 2026-06-30, filed 2026-07-30

Read the full passage →